Rituxan (rituximab) Label - Food and Drug Administration

Rituxan (rituximab) is indicated, in combination with fludarabine and cyclophosphamide (FC), for the treatment of patients with previously untreated and previously treated CD20-positive CLL.

HIGHLIGHTS OF PRESCRIBING INFORMATION RITUXAN should only be ...

The effect of RITUXAN on immune responses was assessed in a randomized, controlled study in patients with RA treated with RITUXAN and methotrexate (MTX) compared to patients treated with MTX alone.

RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA & PV

Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV. See full safety and Boxed Warning for more information.

Rituxan (Genentech, Inc.): FDA Package Insert - MedLibrary.org

RITUXAN, in combination with fludarabine and cyclophosphamide (FC), is indicated for the treatment of adult patients with previously untreated and previously treated CD20-positive CLL.

Rituxan (rituximab) Label - Food and Drug Administration

591 Rituxan® (rituximab) is a genetically engineered chimeric murine/human 592 monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has 593 an approximate molecular...

Dosing Guide | RITUXAN® (rituximab)

Rituxan, in combination with methotrexate, is indicated for rheumatoid arthritis (RA) in adult patients with moderately to severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Administer Rituxan as two 1000-mg intravenous infusions separated by 2 weeks.

Zevalin Enlarged PI (Page 2) - University of New Mexico

RITUXAN is a sterile, clear, colorless, preservative-free liquid concentrate for intravenous (IV) administration. RITUXAN is supplied at a concentration of 10 mg/mL in either 100 mg (10 mL) or 500 mg (50 mL) single-use vials.

RITUXAN- rituximab injection, solution Genentech, Inc.

When used as part of the Zevalin therapeutic regimen, infuse 250 mg/m 2 in accordance with the Zevalin package insert. Refer to the Zevalin package insert for full prescribing information regarding the Zevalin therapeutic regimen.

RITUXAN- rituximab injection, solution Genentech, Inc.

Rituxan (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA).

RITUXAN HYCELA Prescribing Information - Genentech

RITUXAN HYCELA is indicated for the treatment of adult patients with previously untreated diffuse large B-cell lymphoma in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or other anthracycline-based chemotherapy regimens.